Mukand [MUKANDLTD] vs Camlin Fine Sciences [CAMLINFINE] Detailed Stock Comparison

Mukand

NSE
Loading...

Camlin Fine Sciences

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Mukand wins in 12 metrics, Camlin Fine Sciences wins in 6 metrics, with 0 ties. Mukand appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricMukandCamlin Fine SciencesBetter
P/E Ratio (TTM)24.8860.20Mukand
Price-to-Book Ratio2.114.73Mukand
Debt-to-Equity Ratio164.2077.88Camlin Fine Sciences
PEG Ratio1.27-0.82Camlin Fine Sciences
EV/EBITDA13.6827.38Mukand
Profit Margin (TTM)1.69%-6.73%Mukand
Operating Margin (TTM)2.91%-0.95%Mukand
EBITDA Margin (TTM)2.91%N/AN/A
Return on Equity7.99%-15.89%Mukand
Return on Assets (TTM)2.14%-6.87%Mukand
Free Cash Flow (TTM)$432.30M$-157.24MMukand
Dividend Yield2.87%N/AN/A
1-Year Return-17.22%121.05%Camlin Fine Sciences
Price-to-Sales Ratio (TTM)0.422.51Mukand
Enterprise Value$35.09B$47.77BCamlin Fine Sciences
EV/Revenue Ratio0.742.80Mukand
Gross Profit Margin (TTM)24.41%44.07%Camlin Fine Sciences
Revenue per Share (TTM)$330$96Mukand
Earnings per Share (Diluted)$5.57$3.77Mukand
Beta (Stock Volatility)0.680.33Camlin Fine Sciences
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Mukand vs Camlin Fine Sciences Stock Performance Analysis

Loading Price Chart...

Mukand
Camlin Fine Sciences
Mukand Stock Overview | Camlin Fine Sciences Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Mukand2.72%-2.22%-0.96%18.36%39.51%2.53%
Camlin Fine Sciences-0.40%2.82%5.93%-25.11%30.76%62.97%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Mukand-17.22%34.38%163.91%316.34%80.69%37.03%
Camlin Fine Sciences121.05%92.41%101.02%120.02%148.99%148.99%

News Based Sentiment: Mukand vs Camlin Fine Sciences

Mukand

News based Sentiment: MIXED

Mukand Ltd. showed a mixed bag of results this month, with strong profitability improvements offset by declining revenue. The share price reflected this uncertainty with notable fluctuations, creating a cautiously optimistic outlook for investors. The combination of positive earnings and revenue concerns makes this a significant, yet complex, month for the company.

View Mukand News Sentiment Analysis

Camlin Fine Sciences

News based Sentiment: MIXED

Camlin Fine Sciences is showing signs of improvement in profitability, but revenue is down due to planned maintenance. Analyst sentiment is mixed, with downgrades and lowered price targets. The company faces ongoing financial challenges and regulatory scrutiny, making it a moderately significant but complex investment story.

View Camlin Fine Sciences News Sentiment Analysis

Performance & Financial Health Analysis: Mukand vs Camlin Fine Sciences

MetricMUKANDLTDCAMLINFINE
Market Information
Market Cap i₹20.13B₹42.76B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i163,998471,733
90 Day Avg. Volume i212,219379,135
Last Close₹139.20₹226.04
52 Week Range₹84.40 - ₹177.30₹95.59 - ₹333.30
% from 52W High-21.49%-32.18%
All-Time High₹212.80 (Jan 01, 2024)₹333.30 (Jun 26, 2025)
% from All-Time High-34.59%-32.18%
Growth Metrics
Quarterly Revenue Growth-0.10%0.07%
Quarterly Earnings Growth0.19%0.07%
Financial Health
Profit Margin (TTM) i0.02%-0.07%
Operating Margin (TTM) i0.03%-0.01%
Return on Equity (TTM) i0.08%-0.16%
Debt to Equity (MRQ) i164.2077.88
Cash & Liquidity
Book Value per Share (MRQ)₹65.72₹47.98
Cash per Share (MRQ)₹1.83₹7.56
Operating Cash Flow (TTM) i₹-395,700,000₹-1,435,453,000
Levered Free Cash Flow (TTM) i₹758.90M₹-1,390,459,000
Dividends
Last 12-Month Dividend Yield i2.87%N/A
Last 12-Month Dividend i₹4.00₹0.00

Valuation & Enterprise Metrics Analysis: Mukand vs Camlin Fine Sciences

MetricMUKANDLTDCAMLINFINE
Price Ratios
P/E Ratio (TTM) i24.8860.20
Forward P/E iN/A19.92
PEG Ratio i1.27-0.82
Price to Sales (TTM) i0.422.51
Price to Book (MRQ) i2.114.73
Market Capitalization
Market Capitalization i₹20.13B₹42.76B
Enterprise Value i₹35.09B₹47.77B
Enterprise Value Metrics
Enterprise to Revenue i0.742.80
Enterprise to EBITDA i13.6827.38
Risk & Other Metrics
Beta i0.680.33
Book Value per Share (MRQ) i₹65.72₹47.98

Financial Statements Comparison: Mukand vs Camlin Fine Sciences

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)MUKANDLTDCAMLINFINE
Revenue/Sales i₹11.29B₹4.24B
Cost of Goods Sold i₹8.53B₹2.37B
Gross Profit i₹2.76B₹1.87B
Research & Development iN/AN/A
Operating Income (EBIT) i₹328.80M₹21.09M
EBITDA i₹859.30M₹275.58M
Pre-Tax Income i₹376.70M₹-42.64M
Income Tax i₹86.40M₹-100,000
Net Income (Profit) i₹290.30M₹-106.81M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)MUKANDLTDCAMLINFINE
Cash & Equivalents i₹216.00M₹1.04B
Total Current Assets i₹27.07B₹11.83B
Total Current Liabilities i₹24.18B₹8.46B
Long-Term Debt i₹1.02B₹2.93B
Total Shareholders Equity i₹9.50B₹8.75B
Retained Earnings i₹5.70B₹996.35M
Property, Plant & Equipment i₹5.37B₹35.37M

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)MUKANDLTDCAMLINFINE
Operating Cash Flow iN/AN/A
Capital Expenditures iN/AN/A
Free Cash Flow iN/AN/A
Debt Repayment iN/AN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricMUKANDLTDCAMLINFINE
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Average Daily Volume (10 Day) i163,998471,733
Average Daily Volume (90 Day) i212,219379,135
Shares Outstanding i144.50M187.92M
Float Shares i30.30M82.57M
% Held by Insiders i0.77%0.46%
% Held by Institutions i0.01%0.13%

Dividend Analysis & Yield Comparison: Mukand vs Camlin Fine Sciences

MetricMUKANDLTDCAMLINFINE
Last 12-Month Dividend i₹4.00₹0.00
Last 12-Month Dividend Yield i2.87%N/A
3-Year Avg Annual Dividend i₹2.50₹0.00
3-Year Avg Dividend Yield i1.28%N/A
3-Year Total Dividends i₹7.50₹0.00
Ex-Dividend DateJul 25, 2025N/A